348 related articles for article (PubMed ID: 14696162)
1. Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab.
Philippe F; Larrazet F; Meziane T; Dibie A
Catheter Cardiovasc Interv; 2004 Jan; 61(1):67-73. PubMed ID: 14696162
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the radial and femoral arterial approaches for coronary angioplasty in acute myocardial infarction].
Philippe F; Meziane T; Larrazet F; Dibie A
Arch Mal Coeur Vaiss; 2004 Apr; 97(4):291-8. PubMed ID: 15182071
[TBL] [Abstract][Full Text] [Related]
3. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access.
Choussat R; Black A; Bossi I; Fajadet J; Marco J
Eur Heart J; 2000 Apr; 21(8):662-7. PubMed ID: 10731404
[TBL] [Abstract][Full Text] [Related]
4. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.
Siudak Z; Zawislak B; Dziewierz A; Rakowski T; Jakala J; Bartus S; Noworolnik B; Zasada W; Dubiel JS; Dudek D
Coron Artery Dis; 2010 Aug; 21(5):292-7. PubMed ID: 20453640
[TBL] [Abstract][Full Text] [Related]
5. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.
Bertrand OF; De Larochellière R; Rodés-Cabau J; Proulx G; Gleeton O; Nguyen CM; Déry JP; Barbeau G; Noël B; Larose E; Poirier P; Roy L;
Circulation; 2006 Dec; 114(24):2636-43. PubMed ID: 17145988
[TBL] [Abstract][Full Text] [Related]
6. Safety, feasibility and efficacy of transradial primary angioplasty in patients with acute myocardial infarction.
Valsecchi O; Musumeci G; Vassileva A; Tespili M; Guagliumi G; Gavazzi A; Ferrazzi P
Ital Heart J; 2003 May; 4(5):329-34. PubMed ID: 12848090
[TBL] [Abstract][Full Text] [Related]
7. Radial versus femoral access for rescue percutaneous coronary intervention with adjuvant glycoprotein IIb/IIIa inhibitor use.
Kassam S; Cantor WJ; Patel D; Gilchrist IC; Winegard LD; Rea ME; Bowman KA; Chisholm RJ; Strauss BH
Can J Cardiol; 2004 Dec; 20(14):1439-42. PubMed ID: 15614338
[TBL] [Abstract][Full Text] [Related]
8. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
Eichhöfer J; Horlick E; Ivanov J; Seidelin PH; Ross JR; Ing D; Daly P; Mackie K; Ridley B; Schwartz L; Barolet A; Dzavík V
Am Heart J; 2008 Nov; 156(5):864-70. PubMed ID: 19061699
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
[TBL] [Abstract][Full Text] [Related]
10. Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: results of the FARMI trial.
Brasselet C; Tassan S; Nazeyrollas P; Hamon M; Metz D
Heart; 2007 Dec; 93(12):1556-61. PubMed ID: 17639099
[TBL] [Abstract][Full Text] [Related]
11. Comparison between transradial and transfemoral percutaneous coronary intervention in acute ST-elevation myocardial infarction.
Ibebuogu UN; Cercek B; Makkar R; Dinh H; Kwarteng C; Mirocha J; Hussaini A; Singh S; Dohad S; Shah PK; Khorsandi M; Kar S
Am J Cardiol; 2012 Nov; 110(9):1262-5. PubMed ID: 22840847
[TBL] [Abstract][Full Text] [Related]
12. Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.
Barthélémy O; Silvain J; Brieger D; Mercadier A; Lancar R; Bellemain-Appaix A; Beygui F; Collet JP; Costagliola D; Montalescot G
Catheter Cardiovasc Interv; 2012 Jan; 79(1):104-12. PubMed ID: 22162411
[TBL] [Abstract][Full Text] [Related]
13. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction--the RADIAL-AMI pilot randomized trial.
Cantor WJ; Puley G; Natarajan MK; Dzavik V; Madan M; Fry A; Kim HH; Velianou JL; Pirani N; Strauss BH; Chisholm RJ
Am Heart J; 2005 Sep; 150(3):543-9. PubMed ID: 16169338
[TBL] [Abstract][Full Text] [Related]
14. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
Montalescot G; Barragan P; Wittenberg O; Ecollan P; Elhadad S; Villain P; Boulenc JM; Morice MC; Maillard L; Pansiéri M; Choussat R; Pinton P;
N Engl J Med; 2001 Jun; 344(25):1895-903. PubMed ID: 11419426
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
[TBL] [Abstract][Full Text] [Related]
16. Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction.
Yan ZX; Zhou YJ; Zhao YX; Liu YY; Shi DM; Guo YH; Cheng WJ
Chin Med J (Engl); 2008 May; 121(9):782-6. PubMed ID: 18701040
[TBL] [Abstract][Full Text] [Related]
17. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study.
Romagnoli E; Biondi-Zoccai G; Sciahbasi A; Politi L; Rigattieri S; Pendenza G; Summaria F; Patrizi R; Borghi A; Di Russo C; Moretti C; Agostoni P; Loschiavo P; Lioy E; Sheiban I; Sangiorgi G
J Am Coll Cardiol; 2012 Dec; 60(24):2481-9. PubMed ID: 22858390
[TBL] [Abstract][Full Text] [Related]
18. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
[TBL] [Abstract][Full Text] [Related]
19. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
[TBL] [Abstract][Full Text] [Related]
20. Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
Jong P; Cohen EA; Batchelor W; Lazzam C; Kreatsoulas C; Natarajan MK; Strauss BH
Am Heart J; 2001 Feb; 141(2):218-25. PubMed ID: 11174335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
